RNAi Applications in Therapy Development for Neurodegenerative Disease

E-ISSN： 1873-4286|15|34|3977-3991

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.34, 2009-12, pp. : 3977-3991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease

By Douglas Michael R

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 695-705

Informa Healthcare

Access to resources Recommend Favorite

Antiviral applications of RNAi for coronavirus

By Wu Chang-Jer Chan Yi-Lin

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 89-97

Informa Healthcare

Access to resources Recommend Favorite

RNAi Silencing in Mouse Models of Neurodegenerative Diseases

Current Drug Delivery, Vol. 4, Iss. 2, 2007-04 ,pp. : 161-167

Bentham Science Publishers

Access to resources Recommend Favorite

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio Bernardi Giorgio Orlacchio Aldo Martino Sabata

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 615-626

Bentham Science Publishers

Access to resources Recommend Favorite